AAAAAA

   
Results: 1-13 |
Results: 13
LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE
Authors: DOMBERNOWSKY P SMITH I FALKSON G LEONARD R PANASCI L BELLMUNT J BEZWODA W GARDIN G GUDGEON A MORGAN M FORNASIERO A HOFFMANN W MICHEL J HATSCHEK T TJABBES T CHAUDRI HA HORNBERGER U TRUNET PF
Citation: P. Dombernowsky et al., LETROZOLE, A NEW ORAL AROMATASE INHIBITOR FOR ADVANCED BREAST-CANCER - DOUBLE-BLIND RANDOMIZED TRIAL SHOWING A DOSE-EFFECT AND IMPROVED EFFICACY AND TOLERABILITY COMPARED WITH MEGESTROL-ACETATE, Journal of clinical oncology, 16(2), 1998, pp. 453-461
POTENTIATION OF CHLORAMBUCIL CYTOTOXICITY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA BY INHIBITION OF DNA-DEPENDENT PROTEIN-KINASE ACTIVITY USING WORTMANNIN
Authors: CHRISTODOULOPOULOS G MULLER C SALLES B KAZMI R PANASCI L
Citation: G. Christodoulopoulos et al., POTENTIATION OF CHLORAMBUCIL CYTOTOXICITY IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA BY INHIBITION OF DNA-DEPENDENT PROTEIN-KINASE ACTIVITY USING WORTMANNIN, Cancer research, 58(9), 1998, pp. 1789-1792
DNA-DEPENDENT PROTEIN-KINASE ACTIVITY CORRELATES WITH CLINICAL AND IN-VITRO SENSITIVITY OF CHRONIC LYMPHOCYTIC-LEUKEMIA LYMPHOCYTES TO NITROGEN MUSTARDS
Authors: MULLER C CHRISTODOULOPOULOS G SALLES B PANASCI L
Citation: C. Muller et al., DNA-DEPENDENT PROTEIN-KINASE ACTIVITY CORRELATES WITH CLINICAL AND IN-VITRO SENSITIVITY OF CHRONIC LYMPHOCYTIC-LEUKEMIA LYMPHOCYTES TO NITROGEN MUSTARDS, Blood, 92(7), 1998, pp. 2213-2219
PHASE-II STUDY OF A MULTITARGETED ANTIFOLATE (LY231514) (MTA) AS FIRST LINE THERAPY IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC COLORECTAL-CANCER (MCC)
Authors: CRIPPS MC BURNELL M JOLIVET J LOFTERS W FISHER B PANASCI L IGLESIAS J EISENHAUER E
Citation: Mc. Cripps et al., PHASE-II STUDY OF A MULTITARGETED ANTIFOLATE (LY231514) (MTA) AS FIRST LINE THERAPY IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC COLORECTAL-CANCER (MCC), European journal of cancer, 33, 1997, pp. 768-768
RELATIONSHIP BETWEEN NITROGEN-MUSTARD DRUG-RESISTANCE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND PROTEIN EXPRESSION OF BCL-2, BAX, BCL-X AND P53
Authors: CHRISTODOULOPOULOS G FOTOUHI N KRAJEWSKI S REED JC ALAOUIJAMALI M PANASCI L
Citation: G. Christodoulopoulos et al., RELATIONSHIP BETWEEN NITROGEN-MUSTARD DRUG-RESISTANCE IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA (B-CLL) AND PROTEIN EXPRESSION OF BCL-2, BAX, BCL-X AND P53, Cancer letters, 121(1), 1997, pp. 59-67
PHASE-II STUDY OF THE PROGESTERONE ANTAGONIST MIFEPRISTONE IN PATIENTS WITH UNTREATED METASTATIC BREAST-CARCINOMA - A NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY
Authors: PERRAULT D EISENHAUER EA PRITCHARD KI PANASCI L NORRIS B VANDENBERG T FISHER B
Citation: D. Perrault et al., PHASE-II STUDY OF THE PROGESTERONE ANTAGONIST MIFEPRISTONE IN PATIENTS WITH UNTREATED METASTATIC BREAST-CARCINOMA - A NATIONAL-CANCER-INSTITUTE OF CANADA CLINICAL-TRIALS GROUP-STUDY, Journal of clinical oncology, 14(10), 1996, pp. 2709-2712
SENSITIZATION TO DOXORUBICIN RESISTANCE IN BREAST CANCEL CELL-LINES BY TAMOXIFEN AND MEGESTROL-ACETATE
Authors: PANASCI L JEANCLAUDE BJ VASILESCU D MUSTAFA A DAMIAN S DAMIAN Z GEORGES E LIU Z BATIST G LEYLANDJONES B
Citation: L. Panasci et al., SENSITIZATION TO DOXORUBICIN RESISTANCE IN BREAST CANCEL CELL-LINES BY TAMOXIFEN AND MEGESTROL-ACETATE, Biochemical pharmacology, 52(7), 1996, pp. 1097-1102
ENHANCED HOST-CELL REACTIVATION CAPACITY AND EXPRESSION OF DNA-REPAIRGENES IN HUMAN BREAST-CANCER CELLS RESISTANT TO BI-FUNCTIONAL ALKYLATING-AGENTS
Authors: YEN L WOO A CHRISTOPOULOPOULOS G BATIST G PANASCI L ROY R MITRA S ALAOUIJAMALI MA
Citation: L. Yen et al., ENHANCED HOST-CELL REACTIVATION CAPACITY AND EXPRESSION OF DNA-REPAIRGENES IN HUMAN BREAST-CANCER CELLS RESISTANT TO BI-FUNCTIONAL ALKYLATING-AGENTS, Mutation research. DNA repair, 337(3), 1995, pp. 179-189
COMBINATION CHEMOTHERAPY FOR METASTATIC OR RECURRENT CARCINOMA OF THEBREAST - A RANDOMIZED PHASE-III TRIAL COMPARING CAF VERSUS VATH VERSUS VATH ALTERNATING WITH CMFVP - CANCER AND LEUKEMIA GROUP-B STUDY-8281
Authors: AISNER J CIRRINCIONE C PERLOFF M PERRY M BUDMAN D ABRAMS J PANASCI L MUSS H CITRON M HOLLAND J WOOD W HENDERSON IC
Citation: J. Aisner et al., COMBINATION CHEMOTHERAPY FOR METASTATIC OR RECURRENT CARCINOMA OF THEBREAST - A RANDOMIZED PHASE-III TRIAL COMPARING CAF VERSUS VATH VERSUS VATH ALTERNATING WITH CMFVP - CANCER AND LEUKEMIA GROUP-B STUDY-8281, Journal of clinical oncology, 13(6), 1995, pp. 1443-1452
MALIGNANT AND NONMALIGNANT BRAIN-TISSUES DIFFER IN THEIR MESSENGER-RNA EXPRESSION PATTERNS FOR ERCC1 AND ERCC2
Authors: PANASCI L MCQUILLAN A MALAPETSA A CHRISTODOULOPOULOS GR
Citation: L. Panasci et al., MALIGNANT AND NONMALIGNANT BRAIN-TISSUES DIFFER IN THEIR MESSENGER-RNA EXPRESSION PATTERNS FOR ERCC1 AND ERCC2, Cancer research, 55(17), 1995, pp. 3933-3933
EFFECT OF ALKYL-N-PURINE DNA GLYCOSYLASE OVEREXPRESSION ON CELLULAR-RESISTANCE TO BIFUNCTIONAL ALKYLATING-AGENTS
Authors: BRAMSON J OCONNOR T PANASCI L
Citation: J. Bramson et al., EFFECT OF ALKYL-N-PURINE DNA GLYCOSYLASE OVEREXPRESSION ON CELLULAR-RESISTANCE TO BIFUNCTIONAL ALKYLATING-AGENTS, Biochemical pharmacology, 50(1), 1995, pp. 39-44
POTENTIATION OF CHLORAMBUCIL TOXICITY IN B-CLL LYMPHOCYTES USING THE DNA-SYNTHESIS INHIBITORS APHIDICOLIN AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE
Authors: BRAMSON J PANASCI L
Citation: J. Bramson et L. Panasci, POTENTIATION OF CHLORAMBUCIL TOXICITY IN B-CLL LYMPHOCYTES USING THE DNA-SYNTHESIS INHIBITORS APHIDICOLIN AND 1-BETA-D-ARABINOFURANOSYLCYTOSINE, Biochemical pharmacology, 50(1), 1995, pp. 131-135
POLY(ADP-RIBOSE) POLYMERASE CAN BIND MELPHALAN DAMAGED DNA
Authors: BRAMSON J PREVOST J MALAPETSA A NOE AJ POIRIER GG DESNOYERS S ALAOUIJAMALI M PANASCI L
Citation: J. Bramson et al., POLY(ADP-RIBOSE) POLYMERASE CAN BIND MELPHALAN DAMAGED DNA, Cancer research, 53(22), 1993, pp. 5370-5373
Risultati: 1-13 |